纠结于蓝色:解析2型糖尿病情绪困扰与治疗依从性之间的联系
研究对104名2型糖尿病成人进行情绪困扰综合评估,包括糖尿病痛苦和抑郁自评、半结构化抑郁访谈及糖化血红蛋白检测,并电子监测随后3个月用药依从性。结果显示基线糖尿病痛苦是依从性的独立预测因子,抑郁自评中的躯体症状而非认知情感症状独立预测不依从。
要点
- 糖尿病相关痛苦和抑郁症状严重程度是2型糖尿病用药不依从的风险因素。
- 抑郁自评中的躯体症状独立预测不依从,认知情感症状则否。
- 基线糖尿病痛苦可独立预测随访期电子监测和自评的用药依从性。
核心结论
- 研究结果支持糖尿病相关痛苦和抑郁症状严重程度是2型糖尿病用药不依从的风险因素。
- 抑郁测量中的躯体症状而非认知情感症状独立预测不依从,应进一步研究其作为情绪困扰与不依从之间潜在联系的作用。
研究设计与样本
- 研究纳入104名接受2型糖尿病治疗的种族和社会经济背景多样的成人,完成糖尿病痛苦和抑郁的验证性自评、半结构化抑郁访谈,并提供血样检测糖化血红蛋白。
- 随后3个月对104名参与者的用药依从性进行电子监测,同时获取验证性用药依从性自评。
- 采用分层线性回归评估糖尿病痛苦和抑郁对依从性的独立效应。
主要发现
- 3个月平均用药依从性:电子监测为76.1%±25.7%,自评为83.7%±21.9%。
- 较高水平的自评抑郁症状严重程度(P<0.001)、访谈基于的抑郁症状严重程度(P<0.05)和糖尿病相关痛苦(P<0.01)与电子监测和自评不依从呈显著双变量关联。
- 基线糖尿病痛苦是随访期电子监测依从性(β=-0.29;P=0.001)和自评依从性(β=-0.24;P<0.02)的显著独立预测因子。
- 自评抑郁是电子监测和自评依从性的独立预测因子,并使糖尿病痛苦的效应降至不显著;后续模型表明该效应由抑郁的躯体症状而非认知情感症状驱动。
- 访谈基于的抑郁症状结果一致但较弱。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We conducted comprehensive assessments of emotional distress to examine relations with diabetes medication adherence over time. RESEARCH DESIGN AND METHODS: Ethnically and socioeconomically diverse adults treated for type 2 diabetes completed validated self-reports (SRs) for diabetes distress and depression, were administered semistructured depression interviews, and provided blood samples for A1C. Medication adherence among 104 participants was electronically monitored (EM) over the subsequent 3 months; validated SRs of medication adherence were also obtained. Hierarchical linear regression evaluated independent effects of diabetes distress and depression on adherence. RESULTS: Mean ± SD 3-month medication adherence was 76.1% ± 25.7% for EM and 83.7% ± 21.9% for SR. Higher levels of SR (P < 0.001) and interview-based (P < 0.05) depressive symptom severity (P < 0.05) and diabetes-related distress (P < 0.01) showed a significant bivariate association with EM and SR nonadherence. Regression models showed baseline diabetes distress was a significant independent predictor of EM (β = -0.29; P = 0.001) and SR adherence (β = -0.24; P < 0.02) at follow-up. SR depression was an independent predictor of EM and SR adherence and reduced the effects of diabetes distress to nonsignificance. Subsequent models indicated this effect was driven by somatic rather than cognitive-affective symptoms of depression. Results were consistent but weaker for interview-based depressive symptoms. CONCLUSIONS: Findings support diabetes-related distress and depression symptom severity as risk factors for type 2 diabetes medication nonadherence. Somatic symptoms captured by depression measures, but not cognitive-affective symptoms, independently predict nonadherence and should be further investigated as a potential link between emotional distress and nonadherence.
引用
- Gonzalez JS, Kane NS, Binko DH, et al. Tangled Up in Blue: Unraveling the Links Between Emotional Distress and Treatment Adherence in Type 2 Diabetes. Diabetes Care. 2016. PMID: 27797932
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。